Strategic Planning Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
WAM
CRM
Strategic Planning Group's LLY Position: Q2 2026 in Review
Strategic Planning Group increased its Eli Lilly (LLY) stake by 6.9% in Q2 2026, buying an estimated $1.7M and bringing the position to 25,619 shares worth $30.7M. The position accounts for 3.35% of the portfolio, ranked #9.
Strategic Planning Group first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 1,070 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Strategic Planning Group held 25,619 shares of Eli Lilly worth $30.7M as of Q2 2026.
- Strategic Planning Group bought 1,663 Eli Lilly shares in Q2 2026, an estimated $1.7M.
- Eli Lilly made up 3.35% of Strategic Planning Group's portfolio in Q2 2026, its #9 holding.
- Strategic Planning Group first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
- 1,070 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Strategic Planning Group's 13F filing for Q2 2026, filed 16 Jul 2026.